Ultrasound contrast agents applications in diagnostics of renal diseases. Part I. Basic information about structure, principles of work, technical aspects, artifacts and contraindications for use of ultrasound contrast agents (UCA)
Article published in Urologia Polska 2008/61/2.

authors

Andrzej Lewicki1, Maciej Jędrzejczyk, Wiesław Jakubowski, Wojciech Pypno, Andrzej Kidawa, Piotr Marczyński: Oddział Urologii im. J. Kiełkiewicza, Szpital Praski w Warszawie
Zakład Diagnostyki Obrazowej, II Wydział Lekarski Warszawskiego Uniwersytetu Medycznego
Klinika Urologii, II Zespół Dydaktyki Urologicznej, Centrum Medycznego Kształcenia Podyplomowego w Warszawie

keywords

kidney microbubbles ultrasonography ultrasound contrast agents

summary

Introduction. Ultrasonography is at present the basic examination in diagnostics of urogenital diseases, including kidneys. Although a big progress in technical aspects took place in this method in the last three decades continually there is a need to improve precision of recognition. New ultrasound techniques are to shorten diagnostic algorithm and establishing correct diagnosis during the first examination. One of them is contrast-enhanced ultrasonography (CEUS).

The aim of the study. The aim of this study is to demonstrate basic information about structure, principles of work, technical aspects, artifacts and contraindications for use of ultrasound contrast agents (UCA).

Methods. The cited data were obtained from both original and review papers published in the urological and imaging descriptions.

Conclusions. Contrast-enhanced ultrasonography is a new, valuable technique which can give additional information to conventional, grey-scale examination. Use of microbubbles’ proprieties can provide diagnostic range extension of performed examinations.

references

Gramiak R, Shah PM: Echocardiography of the aortic root. Invest Radiol 1968, 3, 356-366.
Burns P, Wilson SR: Microbubble contrast for radiological imaging: 1.Principles. Ultrasound Quarterly 2006, 22, 5-18.
McCulloh M, Gresser C, Moos S et al: Ultrasound Contrast Physics: A Series on Contrast Echocardiography, Article 3. J Am Soc Echocardiogr 2000, 13, 959-967.
Szopiński K: Ultrasonograficzne środki kontrastujące; w Małek G (red): Ultrasonografia dopplerowska. Zastosowania kliniczne. Medipage, 2003, t 2, str. 175-182.
Ultrasound – Technology Information Portal. Ultrasound Contrast Agents. Dostępne pod: http: www.us-tip.com.
Sidhu PS: Physiological concepts of contrast-enhanced ultrasonography; w Albrecht T, D’Onofrio M, Frauscher F et al: Contrast-enhanced general purpose ultrasound. Springer, 2005, str. 9-15.
Correas JM, Bridal L, Lesavre A et al: Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001, 11, 1316-1328.
Jakobsen JA, Correas JM: Ultrasound contrast agents and their use in urogenital radiology: status and prospects. Eur Radiol 2001, 11, 2082-2091.
Cosgrove D: Advances in contrast agent imaging using Cadence™ contrast pulse sequencing technology (CPS) and SonoVue®. Eur Radiol Suppl 2004, 14, P1-P3.
Bauer A, Solbiati L: Ultrasound contrast agents; w Solbiati L, Martegani A, Leen E, Correas JM, Burns PN, Becker D: Contrast – enhanced ultrasound of liver diseases. Springer 2003, str. 21-26.
Correas JM, Claudon M, Tranquart F, Helenon O: The kidney: imaging with microbubble contrast agents. Ultrasound Quartely 2006, 22, str. 53-66.
Burns PN: Contrast ultrasound technology; w Solbiati L, Martegani A, Leen E, Correas JM, Burns PN, Becker D: Contrast – enhanced ultrasound of liver diseases. Springer 2003, str. 1-18.
EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasound. Ultraschall in Med 2004, 25, 249-256.
Greis Ch: Technology overview: SonoVue (Bracco, Milan); w Cosgrove D: Advances in contrast agent imaging using Cadence™ contrast pulse sequencing technology (CPS) and SonoVue®. Eur Radiol Suppl 2004, 14, P11-P15.
Lim A, Cosgrove D: Functional studies w Cosgrove D: Advances in contrast agent imaging using Cadence™ contrast pulse sequencing technology (CPS) and SonoVue®. Eur Radiol Suppl 2004, 14, P110-P115.
Piscaglia F, Bolondi L: The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Medicine Biol 2006, 32, 1369-1375.
Ulotka informacyjna dotycząca preparatu SonoVue.

correspondence